D.). The authors declare no financial or commercial conflict of interest. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the

authors. “
“The signal transducer and activator of transcription 3 (STAT3) transcription factor pathway plays an important role in many biological phenomena. STAT3 transcription is triggered by cytokine-associated signals. Here, we use isolated human B cells to analyse the role of STAT3 in interleukin (IL)-10 induced terminal B cell differentiation and in immunoglobulin (Ig)A production

selleck chemicals as a characteristic readout of IL-10 signalling. We identified optimal conditions for inducing in-vitro IgA production by purified blood naive B cells using IL-10 and soluble CD40L. We show that soluble CD40L consistently induces the phosphorylation of nuclear factor (NF)-κB p65 but not of STAT3, while IL-10 induces the phosphorylation of STAT3 but not of NF-κB p65. Interestingly, while soluble CD40L and IL-10 were synergistic in driving the terminal maturation of B cells into IgA-producing plasma cells, they did not Epacadostat in vitro co-operate earlier in the pathway with regard to the transcription factors NF-κB p65 or STAT3. Blocking either NF-κB p65 or STAT3 profoundly altered the production of IgA and mRNA for activation-induced cytidine deaminase (AID), an enzyme strictly

necessary for Ig heavy chain recombination. Finally, C-X-C chemokine receptor type 7 (CXCR-7) the STAT3 pathway was directly activated by IL-10, while IL-6, the main cytokine otherwise known for activating the STAT3 pathway, did not appear to be involved in IL-10-induced-STAT3 activation. Our results suggest that STAT3 and NF-κB pathways co-operate in IgA production, with soluble CD40L rapidly activating the NF-κB pathway, probably rendering STAT3 probably more reactive to IL-10 signalling. This novel role for STAT3 in B cell development reveals a potential therapeutic or vaccine target for eliciting IgA humoral responses at mucosal interfaces. Naive mature B cells express both immunoglobulins (Ig) M and D. Antigen and T cell-dependent or -independent activation induces class switch recombination (CSR) of differentiated B cell genes, a molecular mechanism involving Ig heavy chain (CH) gene rearrangements. After such activation, B cells produce IgG, IgA or IgE antibodies [1]. Whatever the mechanism, antibody production involves activation-induced cytidine deaminase (AID), an enzyme strictly necessary for Ig heavy chain recombination [2]. IgA constitutes the most abundant antibody class in the gut, where it contributes to immune protection against certain pathogens. Within the gut, low- and high-affinity IgA is produced in the lamina propria (LP) and Peyer’s patches, respectively [3].